Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
Amyris, a leader in synthetic biotechnology, will present at the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amyris, a leader in synthetic biotechnology, will present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 14, 2020, at 10:00 a.m. ET. CEO John Melo will discuss the company's performance and progress, with a live webcast available on its investor relations website. Amyris specializes in sustainable ingredients for Clean Health and Beauty markets, owning three consumer brands: Biossance, Pipette, and Purecane. The presentation will not include a Q&A session.
Details
News Market Reaction – AMRS
The recorded move for AMRS in the trading session of this news was -1.31%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Sept. 8, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo, President and Chief Executive Officer, will present during the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on Monday, September 14, 2020. The company will also be participating in virtual one-on-one meetings during the conference.
Amyris will provide an update on the progress and performance of its business during the presentation, which is scheduled for Monday, September 14, at 10:00 a.m. ET. A live webcast of the presentation including slides and a replay will be available on the investor relations section of the company's website at http://investors.amyris.com. Due to the format of the virtual conference, no audience question and answer session will be available.
About Amyris
Amyris (Nasdaq: AMRS) is a science and technology leader in the research, development and production of sustainable ingredients for the Clean Health & Beauty and Flavors & Fragrances markets. Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence. Our ingredients are included in over 3,000 products from the world's top brands, reaching more than 200 million consumers. Amyris is proud to own three consumer brands - all built around its No Compromise® promise of clean ingredients: Biossance™ clean beauty skincare, Pipette™ clean baby skincare and Purecane™, a zero-calorie sweetener naturally derived from sugarcane. For more information, please visit www.amyris.com.
Amyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.
View original content to download multimedia:http://www.prnewswire.com/news-releases/amyris-to-present-at-hc-wainwright-22nd-annual-global-investment-conference-on-september-14-2020-301125140.html
SOURCE Amyris, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.